Cooper EBITDA 2010-2025 | COO

Cooper EBITDA for the quarter ending January 31, 2025 was $0.273B, a 9.24% increase year-over-year.

  • Cooper 2024 EBITDA was 1.081B, a 19.98% increase from 2023.
  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Cooper EBITDA 2010-2025 | COO

  • Cooper 2024 EBITDA was 1.081B, a 19.98% increase from 2023.
  • Cooper 2023 EBITDA was 0.901B, a 5.52% increase from 2022.
  • Cooper 2022 EBITDA was 0.854B, a 4.74% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$75.5B
Becton Dickinson (BDX)$65.3B
Cardinal Health (CAH)$30.6B
Straumann Holding AG (SAUHY)$23.7B
Labcorp (LH)$20.7B
Align Technology (ALGN)$15.1B
West Pharmaceutical Services (WST)$14.6B
Henry Schein (HSIC)$9.7B
Merit Medical Systems (MMSI)$6.2B
DENTSPLY SIRONA (XRAY)$3.8B
Patterson (PDCO)$2.7B
CONMED (CNMD)$1.9B
STAAR Surgical (STAA)$876M
Lifevantage (LFVN)$230M
Pro-Dex (PDEX)$112M